UNSPSC 85751323: Removal of autologous tissue substitute from prostate and seminal vesicles, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to removal of autologous tissue substitute from prostate and seminal vesicles, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0VP447Z

UNSPSC 85751323 Removal of autologous tissue substitute from prostate and seminal vesicles, percutaneous endoscopic approach (Commodity) shows minimal alignment with recent state and local procurement activity. The code nominally describes a highly specialized surgical procedure, yet the six state and local solicitations posted in recent months under this code include medical evaluation services for pension disability determinations, surgical carve-out benefits for government employee health plans, occupational health surveillance, emergency medical services for detained youth, pharmacy benefit management, and temporary health professional staffing. None of these opportunities involve the specific urological procedure the code names. The mismatch suggests either systematic miscoding by issuing bodies or that this code is being used as a catch-all for healthcare services procurement absent a more precise classification.

The issuing bodies include city retirement offices (City of Phoenix), large municipalities (City of Long Beach, County of Santa Clara Health System), state transportation departments (Washington State Department of Transportation), county probation departments (Harris County Juvenile Probation Department), and county board commissioners (Collier County Board of County Commissioners). Recent opportunities are concentrated in Arizona, California, Washington, and Florida, with no evident pattern of repeat buyers under this code. The most substantial recent activity is the Collier County Pharmacy Benefit Management Services RFP (annual historical spend approximately $8.7 million, initial three-year term through December 31, 2028) and the City of Long Beach surgical carve-out benefit program RFP for approximately 3,800 enrolled employees and retirees. Unless the code's scope is reinterpreted to encompass broader healthcare procurement, this code does not represent meaningful opportunity for vendors focused on the procedure its name describes.